1887

Abstract

is an important cause of antibiotic-associated diarrhoea. The simultaneous presence of different strains in individual faecal samples has not yet been established, but is important for epidemiological studies. Recurrences of -associated diarrhoea (CDAD) are observed in 15–20 % of patients and have been reported as relapses or reinfections with a new strain. In a period of 1 year, 28 faecal samples from 23 patients with a first episode of CDAD were collected at the Leiden University Medical Centre. In addition, 52 faecal samples from 23 patients, from three different hospitals, with one ( = 19), two ( = 2) or three ( = 2) recurrences were studied. PCR-ribotyping was applied as the standard typing method for the isolates. The toxinogenic and clindamycin-resistance profiles of the isolates was determined by PCR. Of 23 patients with a first episode of CDAD, two (8.7 %) harboured two different types, with no differences in toxinogenicity or clindamycin resistance, within one faecal sample. One of these 23 patients showed two types in three faecal samples from the same episode. Of the 23 patients with recurrences, six (26 %) showed a different strain type isolated in a recurrent episode. The number of cases of multiple strains in faecal samples from patients with a first episode of CDAD did not differ significantly from the number of different strains present in recurrent episodes (chi-square test, ⩽ 0.2). This observation limits the application of typing methods for studying the epidemiology of CDAD.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.45825-0
2005-02-01
2019-10-15
Loading full text...

Full text loading...

/deliver/fulltext/jmm/54/2/JM540213.html?itemId=/content/journal/jmm/10.1099/jmm.0.45825-0&mimeType=html&fmt=ahah

References

  1. al-Barrak, A., Embil, J., Dyck, B., Olekson, K., Nicoll, D., Alfa, M. & Kabani, A. ( 1999;). An outbreak of toxin A negative, toxin B positive Clostridium difficile-associated diarrhea in a Canadian tertiary-care hospital. Can Commun Dis Rep 25, 65–69.
    [Google Scholar]
  2. Alfa, M. J., Kabani, A., Lyerly, D. & 7 other authors ( 2000;). Characterization of a toxin A-negative, toxin B-positive strain of Clostridium difficile responsible for a nosocomial outbreak of Clostridium difficile-associated diarrhea. J Clin Microbiol 38, 2706–2714.
    [Google Scholar]
  3. Aspinall, S. T. & Hutchinson, D. N. ( 1992;). New selective medium for isolating Clostridium difficile from faeces. J Clin Pathol 45, 812–814.[CrossRef]
    [Google Scholar]
  4. Barbut, F., Richard, A., Hamadi, K., Chomette, V., Burghoffer, B. & Petit, J. C. ( 2000;). Epidemiology of recurrences or reinfections of Clostridium difficile-associated diarrhea. J Clin Microbiol 38, 2386–2388.
    [Google Scholar]
  5. Barroso, L. A., Wang, S. Z., Phelps, C. J., Johnson, J. L. & Wilkins, T. D. ( 1990;). Nucleotide sequence of Clostridium difficile toxin B gene. Nucleic Acids Res 18, 4004. 4004.[CrossRef]
    [Google Scholar]
  6. Bidet, P., Barbut, F., Lalande, V., Burghoffer, B. & Petit, J. C. ( 1999;). Development of a new PCR-ribotyping method for Clostridium difficile based on ribosomal RNA gene sequencing. FEMS Microbiol Lett 175, 261–266.[CrossRef]
    [Google Scholar]
  7. Borriello, S. P. & Honour, P. ( 1983;). Concomitance of cytotoxigenic and non-cytotoxigenic Clostridium difficile in stool specimens. J Clin Microbiol 18, 1006–1007.
    [Google Scholar]
  8. Cohen, S. H., Tang, Y. J. & Silva, J. Jr ( 2001;). Molecular typing methods for the epidemiological identification of Clostridium difficile strains. Expert Rev Mol Diagn 1, 61–70.[CrossRef]
    [Google Scholar]
  9. Devlin, H. R., Au, W., Foux, L. & Bradbury, W. C. ( 1987;). Restriction endonuclease analysis of nosocomial isolates of Clostridium difficile. J Clin Microbiol 25, 2168–2172.
    [Google Scholar]
  10. Do, A. N., Fridkin, S. K., Yechouron, A., Banerjee, S. N., Killgore, G. E., Bourgault, A. M., Jolivet, M. & Jarvis, W. R. ( 1998;). Risk factors for early recurrent Clostridium difficile-associated diarrhea. Clin Infect Dis 26, 954–959.[CrossRef]
    [Google Scholar]
  11. Dove, C. H., Wang, S. Z., Price, S. B., Phelps, C. J., Lyerly, D. M., Wilkins, T. D. & Johnson, J. L. ( 1990;). Molecular characterization of the Clostridium difficile toxin A gene. Infect Immun 58, 480–488.
    [Google Scholar]
  12. Fekety, R., McFarland, L. V., Surawicz, C. M., Greenberg, R. N., Elmer, G. W. & Mulligan, M. E. ( 1997;). Recurrent Clostridium difficile diarrhea: characteristics of and risk factors for patients enrolled in a prospective, randomized, double-blinded trial. Clin Infect Dis 24, 324–333.[CrossRef]
    [Google Scholar]
  13. Garcia, A., Garcia, T. & Perez, J. L. ( 1997;). Proline-aminopeptidase test for rapid screening of Clostridium difficile. J Clin Microbiol 35, 3007. 3007.
    [Google Scholar]
  14. Geric, B., Johnson, S., Gerding, D. N., Grabnar, M. & Rupnik, M. ( 2003;). Frequency of binary toxin genes among Clostridium difficile strains that do not produce large clostridial toxins. J Clin Microbiol 41, 5227–5232.[CrossRef]
    [Google Scholar]
  15. Johnson, S., Sambol, S. P., Brazier, J. S., Delmée, M., Avesani, V., Merrigan, M. M. & Gerding, D. N. ( 2003;). International typing study of toxin A-negative, toxin B-positive Clostridium difficile variants. J Clin Microbiol 41, 1543–1547.[CrossRef]
    [Google Scholar]
  16. Kato, H., Kato, N., Watanabe, K. & 7 other authors ( 1998;). Identification of toxin A-negative, toxin B-positive Clostridium difficile by PCR. J Clin Microbiol 36, 2178–2182.
    [Google Scholar]
  17. Kato, H., Kato, N., Katow, S., Maegawa, T., Nakamura, S. & Lyerly, D. M. ( 1999;). Deletions in the repeating sequences of the toxin A gene of toxin A-negative, toxin B-positive Clostridium difficile strains. FEMS Microbiol Lett 175, 197–203.[CrossRef]
    [Google Scholar]
  18. Kuijper, E. J., de Weerdt, J., Kato, H., Kato, N., van Dam, A. P., van der Vorm, E. R., Weel, J., van Rheenen, C. & Dankert, J. ( 2001;). Nosocomial outbreak of Clostridium difficile-associated diarrhoea due to a clindamycin-resistant enterotoxin A-negative strain. Eur J Clin Microbiol Infect Dis 20, 528–534.[CrossRef]
    [Google Scholar]
  19. McFarland, L. V., Surawicz, C. M., Rubin, M., Fekety, R., Elmer, G. W. & Greenberg, R. N. ( 1999;). Recurrent Clostridium difficile disease: epidemiology and clinical characteristics. Infect Control Hosp Epidemiol 20, 43–50.[CrossRef]
    [Google Scholar]
  20. McFarland, L. V., Elmer, G. W. & Surawicz, C. M. ( 2002;). Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease. Am J Gastroenterol 97, 1769–1775.[CrossRef]
    [Google Scholar]
  21. O'Neill, G. L., Beaman, M. H. & Riley, T. V. ( 1991;). Relapse versus reinfection with Clostridium difficile. Epidemiol Infect 107, 627–635.[CrossRef]
    [Google Scholar]
  22. Sharp, J. & Poxton, I. R. ( 1985;). An immunochemical method for fingerprinting Clostridium difficile. J Immunol Methods 83, 241–248.[CrossRef]
    [Google Scholar]
  23. Stubbs, S. L., Brazier, J. S., O'Neill, G. L. & Duerden, B. I. ( 1999;). PCR targeted to the 16S-23S rRNA gene intergenic spacer region of Clostridium difficile and construction of a library consisting of 116 different PCR ribotypes. J Clin Microbiol 37, 461–463.
    [Google Scholar]
  24. Sutcliffe, J., Grebe, T., Tait-Kamradt, A. & Wondrack, L. ( 1996;). Detection of erythromycin-resistant determinants by PCR. Antimicrob Agents Chemother 40, 2562–2566.
    [Google Scholar]
  25. Tang-Feldman, Y., Mayo, S., Silva, J. J. Jr & Cohen, S. H. ( 2003;). Molecular analysis of Clostridium difficile strains isolated from 18 cases of recurrent clostridium difficile-associated diarrhea. J Clin Microbiol 41, 3413–3414.[CrossRef]
    [Google Scholar]
  26. van den Berg, R. J., Claas, E. C., Oyib, D. H., Klaassen, C. H., Dijkshoorn, L., Brazier, J. S. & Kuijper, E. J. ( 2004;). Characterization of toxin A-negative, toxin B-positive Clostridium difficile isolates from outbreaks in different countries by amplified fragment length polymorphism and PCR ribotyping. J Clin Microbiol 42, 1035–1041.[CrossRef]
    [Google Scholar]
  27. Wilcox, M. H. & Spencer, R. C. ( 1992;). Clostridium difficile infection: responses, relapses and re-infections. J Hosp Infect 22, 85–92.[CrossRef]
    [Google Scholar]
  28. Wilcox, M. H., Fawley, W. N., Settle, C. D. & Davidson, A. ( 1998;). Recurrence of symptoms in Clostridium difficile infection – relapse or reinfection? J Hosp Infect 38, 93–100.[CrossRef]
    [Google Scholar]
  29. Young, G. P., Bayley, N., Ward, P., St John, D. J. & McDonald, M. I. ( 1986;). Antibiotic-associated colitis caused by Clostridium difficile: relapse and risk factors. Med J Aust 144, 303–306.
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.45825-0
Loading
/content/journal/jmm/10.1099/jmm.0.45825-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error